## BG: Bunge Global SA - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -4.7% below STRENGTH zone (3.0-6.0%); PEG 1.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-7.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($83.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Bunge Global SA (NYSE:BG) Given Average Recommendation of "Buy" by Brokerages**
- Source: MarketBeat | 20251223T084752 | Bullish | Relevance: 100%
- Bunge Global SA (NYSE:BG) has received a consensus "Buy" rating from nine brokerages, with an average 12-month price target of $109.13. This follows recent upgrades from firms like Morgan Stanley and Bank of America. Despite some insider selling, institutional ownership in Bunge Global remains high at 86.23%, with new significant investments from Glencore and Norges Bank.

**2. Bunge Global SA $BG Shares Acquired by Voya Investment Management LLC**
- Source: MarketBeat | 20251222T125408 | Bullish | Relevance: 100%
- Voya Investment Management LLC significantly increased its stake in Bunge Global SA (NYSE:BG) during the 3rd quarter, acquiring an additional 266,827 shares to own a total of 303,928 shares valued at $24,694,000. Other institutional investors also adjusted their holdings in Bunge Global, which reported strong year-over-year revenue growth and outperformed earnings estimates in its last quarterly report. Analysts maintain a "Buy" rating for Bunge Global, with a consensus target price of $109.13.

**3. Podcasts that sparked conversation in 2025**
- Source: CHS Inc. | 20251222T170915 | Somewhat-Bullish | Relevance: 70%
- CHS Inc. launched its "It Takes a Co-opâ„¢" podcast in 2025, focusing on agricultural, energy, and transportation topics within the cooperative system. This article highlights four key episodes from the year, covering global supply chain adaptation, proactive fertilizer planning, managing agricultural volatility, and the critical role of rail in moving ag products. These episodes feature insights from CHS leaders on how the cooperative system addresses market forces and supports American farmers.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $120 | $95 | +26% |
| 2025-12-02 | B of A Securiti | $112 | $95 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | up | Overweight |
| 2025-12-02 | B of A Securiti | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 66.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Glencore Plc: 17.0% (+100.0%)
- Canada Pension Plan : 13.6% (+999418.6%)
- Vanguard Group Inc: 8.7% (+0.8%)
- Capital World Invest: 8.4% (+4.5%)
- Blackrock Inc.: 8.2% (-1.6%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-7.8% 5d) with bearish MACD, trend may be turning.
2. Near-term weakness: 6.1% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.71 elevated, pricing in significant growth expectations. Forward P/E 9.9x attractive for 19% earnings growth. Revenue growth strong at 36% YoY. Analyst sentiment positive (2 raises, avg +22%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.1B |
| Beta | 0.78 |
| 52W Range | $67.40 - $99.55 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.71 |
| Forward P/E | 9.9 |
| Current P/E | 11.8 |
| YoY Growth | 19.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.1% to -4.7% (-7.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.7pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-0.53), momentum weakening. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.70% (CS: 6) | Weak |
| RSI_14 | 32.9 | Neutral |
| MACD Histogram | -0.53 | Bearish |
| vs SMA20 | 0.949x | Below |
| vs SMA50 | 0.939x | Below |
| vs SMA200 | 1.068x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $88.53
- **Stop Loss:** $83.91 (5.2% risk)
- **Target:** $93.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 129
- **Position Value:** $11,420.37
- **Portfolio %:** 11.42%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-11 (Est: $1.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.97 | $2.27 | +15.3% |
| 2025Q2 | $1.08 | $1.31 | +20.9% |
| 2025Q1 | $1.31 | $1.81 | +38.3% |
| 2024Q4 | $2.25 | $2.13 | -5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*